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1. Introduction 
Despite the advances in operative techniques and perioperative management of patients 
suffering from abdominal aortic aneurysms (AAAs) or occlusive aorto-iliac disease, there are 
many early and late complications related to aortic graft insertion, either in open or 
endovascular approach, that every vascular surgeon should bear in mind. One of the most 
dreaded complication is the infection of prosthetic aortic grafts which continues to be 
problematic despite improvements in biomaterials and fabrication of prosthetics, refinements 
in implantation techniques, and better understanding of the pathogenesis of graft infections. 
This article reviews the epidemiology, pathogenesis, diagnosis, and current state-of –the art 
management of prosthetic aortic graft infections. 
1.1 Incidence and risk factors 
The overall incidence of aortic graft infection has probably changed little in the past two 
decades despite an improved understanding of graft infections and more specified efforts at 
prevention (Perera et al., 2006). The true incidence of graft infections is difficult to establish 
and depends on how one defines the problem (graft infection or graft exposure in a 
nonhealing wound), the graft material (autogenous vein, Dacron, polytetrafluoroethylene 
[PTFE]), the duration of follow-up, and other factors (Chiesa et al., 2002; Perera et al., 2006). 
However, most recent series document an incidence ranging from just under 1% to as high 
as 6%, with an overall incidence of approximately 4% (Bisdas et al., 2010; FitzGerald et al., 
2005). It is estimated that the cost of caring for a patient with an infected vascular graft 
currently averages $40,000 (Ali et al., 2009). 
Both patient variables and technical factors predispose to the development of vascular graft 
infections. Patient factors include disease processes such as diabetes mellitus, obesity, 
uremia, malnutrition, and immunosuppressive states (Yeager et al., 1992). Ulceration or 
infection in an extremity distal to a graft and emergency procedures are also known to 
increase infectious risks (Perera et al., 2006). Wound healing complications, such as cellulitis, 
seroma, lymphocele, hematoma, or skin necrosis, further contribute to graft infections 
(Gutowski, 1998). Reoperation in the early postoperative period for thrombosis or bleeding 
is an additional predisposing factor. Special emphasis should be placed to the higher 
incidence of infection accompanied the implementation of aortofemoral bypass grafts 
compared to aortoiliac grafts, since the groin area is frequently contaminated and prone to 
wound complications (Yeager et al., 1992). 
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1.2 Pathogenesis 
The vast majority of prosthetic aortic graft infections occur as a result of bacterial 
contamination of the perigraft space around the time of original graft placement. Under 
these circumstances, endogenous skin flora constitutes the causative organisms of such 
infections. Most patients who undergo arterial revascularization or aneurysm repair have 
significant numbers of mucin-producing coagulase-negative staphylococci on their skin, and 
at least 15% have methicillin-resistant (MRSA) strains preoperatively (Kieffer et al., 2001). 
Incomplete sterilization of instruments or grafts rarely does play a role in the incidence of 
aortic graft infections, but breaks in sterile technique, particularly during emergency 
procedures, are more common (Valentine, 2001). Graft seeding by bacteria from transected 
lymphatics in the presence of distal extremity infections may be important. Moreover, 
microorganisms from the native arterial thrombus or arteriosclerotic plaque may 
contaminate grafts. Careful culturing of the arterial wall during elective procedures 
demonstrates the presence of microorganisms in about 40% of specimens (Farkas et al., 1993; 
Hsu et al., 2004). Other studies suggest that aortic graft infections increase from 2% to 
approximately 10% if arterial wall cultures are positive, but some authors have concluded 
that bacteria in aneurysm contents is not linked to subsequent graft infections (Macbeth et 
al., 1984). Concomitant contaminated procedures increase the likelihood of prosthetic 
infection and should be avoided whenever possible. Lengthy procedures and those with 
larger blood loss are associated with higher infection rates (Yeager et al., 1992). 
Irrespective of the origin or the type of offending microorganism, the pathogenetic 
mechanism of the ensuing infection represents a common denominator. During the early 
postoperative period, the fluid filled (blood, serum, lymph) perigraft environment is poorly 
perfused and relatively isolated from the natural host defenses (Chiesa et al., 2002). These 
poorly vascularized, perigraft fluid collections serve as a receprive medium for bacteria, 
enabling their survival and proliferation. Any early contamination of the perigraft space 
with even low numbers of bacteria, can lead to eventual prosthetic graft infection. Without 
early contamination, however, the prosthetic material becomes incorporated into 
surrounding, vascularized tissues, which functionally obliterates the perigraft space and, 
after several months, appears to render the graft more resistant to infection. 
As described below in the section of clinical presentation, the prosthetic vascular graft 
infections are classified as early or late depending on presentation before or after four 
months from the time of surgical implantation. Even when considering the pathogenesis of 
late graft infections, the majority of them are caused by graft contamination at the time of 
implantation with indolent disease progression, in a manner identical to that mentioned 
previously in detail. Nevertheless, other mechanisms unique in this subgroup of patients 
with late presentation, comprise transient bacteremia and mechanical erosion of the graft 
into surrounding tissues (Kibria et al., 2010; Lazaris et al., 2009). Erosion into the urinary or 
gastrointestinal tracts or through the skin occurs in 1% to 3% of patients. Graft-enteric fistula 
complicates 0,6% to 2,3% of cases of aortic graft placement (Koshy et al., 2010). Transient 
bacteremia is presumed to be an occasional mechanism for late graft infections. 
1.3 Microbiology 
Staphylococcus species are the most common causative organism of aortic graft infections 
(Kaebnick et al., 1987; Sharp et al., 1994). This fact is consistent with our understanding that 
the pathogenesis of prosthetic graft infection is related to bacterial contamination at the time 
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of graft placement. Staphylococcus epidermidis is the slow-growing, slim-producing 
organism classically causing late, indolent graft infection. The more virulent Staphylococcus 
aureus typically causes early graft infection and frequently is associated with overt signs of 
sepsis. It is estimated that Staphylococcus aureus accounts for approximately 25% to 50% of 
graft infections (FitzGerald et al., 2005). Methicillin-resistant (MRSA) strains of 
Staphylococcus aureus are increasingly common in early infections, and gram-negative 
bacilli, such as Enterobacter, Klebsiella, Escherichia coli, Proteus, and Pseudomonas, have 
also been slowly increasing in frequency (Kitamura et al., 2005). 
For all organisms, bacterial adherence to the prosthetic graft is the initial event in the 
process of graft infection. Adherence is dependent on physical characteristics of the graft, 
such as pore size and surface are, and upon chemical properties, such as hydrophobicity 
(O’Brien & Colin, 1992). The production of an extracellular glycocalyx (mucin, slime) by 
staphylococci promotes adherence to biomaterials and provides protection against host 
defenses. This biofilm decreases antibiotic penetration and impairs phagocyte and antibody 
functions but will stimulate a chronic inflammatory process around an infected prosthesis. 
Organisms that produce a biofilm are more difficult to culture from an infected graft. 
Proteases produced by gram-negative organisms contribute to the higher rates of vessel wall 
necrosis, anastomotic disruption, and pseudoaneurysm formation with infectionfrom these 
bacteria (Kitamura et al., 2005; O’Brien & Colin, 1992). Finally, it is important for every 
vascular surgeon to bear in mind that, in contrast to primary aortic infections, Salmonella 
almost never is the causative organism for prosthetic graft infection. 
1.4 Prevention 
As indicated above, the preponderance of evidence suggests that in the majority of cases 
bacterial seeding of the conduit at the time of implantation leads the way to the 
development of postoperative graft infection whenever such an infection manifests. Based 
on this observation, it seems safe to conclude that careful observation of fundamental 
principles of patient management during that critical perioperative period can minimize the 
incidence of this detrimental complication. At first, prophylactic antibiotics should be 
administered intravenously before the skin incision. Although there is no compelling 
evidence that antibiotic use prevents frank infection, there is good evidence that the 
incidence of surgical site infection is reduced, and wound infection is an important 
contributor to graft infection in many cases (Kayser et al., 1978). The duration of antibiotic 
therapy postoperatively is controversial. Although there is no strong support for such 
policy, it is reasonable to continue antibiotics for 24 hours postoperatively (Barie & 
Eachempati, 2005). Because skin flora is an important source of graft contamination, the 
operative field should be widely cleansed with povidone-iodine solution, and ischemic or 
ulcerative lesions in the limbs should be isolated (Barie & Eachempati, 2005; Mangram et al., 
1999). Lymphatics are another potential route of infection, and thus lymphatic tissue should 
be ligated and sharply divided. Last, the duration of hospitalization during the primary 
aortic graft insertion might interfere with the development of a graft infection at a later 
stage. Patients who are hospitalized for a prolonged time before operative intervention 
undergo an alteration in their microbial flora and may be at an increased risk of developing 
graft infection secondary to colonization with resistant organism (Angle et al, 2002).. 
Thorough investigation has been centered for many years around the potential benefit of 
antibiotic-bonded Dacron and PTFE grafts to resist infection (O’Connor et al., 2006; Wilson, 
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2001). Most work has focused on rifampin-bonded grafts, which have been shown to elute 
the antibiotic at the implantation site for only a few days, possibly limiting their efficacy in 
this regard (Bandyk et al., 2001). Although there is some evidence that they are effective 
against Staphyococcus epidermidis and Staphylococcus aureus, they may have more limited 
efficacy against gram-negative organisms and MRSA Staphylococcus species. 
1.5 Clinical presentation and classification 
Patients with aortic prosthetic graft infection may present early (within 4 months) or late 
(after 4 months) following original graft placement (Orton et al., 2000). Szilagyi classified 
early infections of vascular prostheses into three grades according to the depth of wound 
involvement as assessed by clinical observation and wound exploration (Szilagyi et al., 
1972). Grade I infections involve only the skin (celullitis); Grade II involve the subcutaneous 
tissue; and Grade III involve the prosthesis. Samson has modified the widely used 
classification system of extracavitary vascular graft infections established by Szilagyi 
(Samson, 1988). These modifications allow for more precise prognostication and directed 
treatment. Early graft infections, presented within the first 4 months after implantation, are 
typically caused by Staphylococcus aureus and gram-negative bacilli, and are accompanied 
by systemic signs of infection, including malaise, fever, and leukocytosis. Wound infections, 
anastomotic disruptions with bleeding, and tender groin masses are also common 
presenting signs (Valentine, 2001). Graft thrombosis, physical evidence of pseudoaneurysm, 
and distal embolization may also occur. Acute infection of intraabdominal aortic graft is rare 
but should be suspected when fever, leukocytosis, persistent adynamic ileus, and abdominal 
tenderness are present in the perioperative period without other evident etiologies. 
Most aortic graft infections relate to aortobifemoral grafts and involve one or both the 
inguinal regions. In such cases the manifestation of infection is often obvious and consists in 
development of erythema overlying the graft, a palpable fluid collection, a draining sinus 
tract, or a pseudoaneurysm. The presence of any of the above signs revealed during physical 
examination should be assumed to be indicative of graft infection (Bandyk & Esses, 1994).  
Conversely, the presentation of late-onset infections (presented after the first 4 months after 
implantation) tends to be subtle, without any specific signs or symptoms. Absence of fever 
is not uncommon. These patients are more likely to present with complications of aortic 
graft infection, such as pseudoaneurysm, sepsis or gastrointestinal bleeding as a result of 
erosion of the graft into the gastrointestinal tract, and hydronephrosis (Bandyk & Esses, 
1994). Aortoenteric fistula may involve any segment of the large or small bowel, but the 
third and fourth portions of duodenum are the most common sites. In some instances, the 
anastomosis between the graft and the aorta remains intact, and erosion of the intact graft 
into the intestine causes mucosal bleeding. Alternatively, the anastomosis may communicate 
directly with the intestinal lumen, as a result of a pseudoaneurysm. A ‘’herald bleed’’ from 
mucosal erosion usually precedes massive gastrointestinal bleeding from an established 
aortoenteric fistula (Montgomery & Wilson, 1996). 
1.6 Diagnosis 
The diagnosis of aortic graft infections is usually made on the ground of clinical findings, 
supported by radiological and microbiological investigations (FitzGerald et al., 2005). When 
a vascular surgeon raises the possibility of prosthetic graft infection, there are numerous 
modalities in his/her armamentarium that he/she has to recourse to in order to confirm or 
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exclude that possibility. Unfortunately, under some circumstances, no laboratory or imaging 
modality can completely exclude the likelihood of aortic graft infection, and operative 
exploration is necessary to establish its diagnosis. In cases when signs of infection are 
evident in the inguinal region, duplex ultrasonography is often considered the best initial 
screening test. Features such as perigraft fluid or anastomotic pseudoaneurysm found at 
ultrasound, represent supportive evidence to the clinical suspicion. In addition, duplex 
ultrasound evaluates the patency of peripheral vessels of the afflicted extremity, playing a 
central role in drawing a potential surgical plan (Calligaro & Feith, 1991). It is of less benefit 
for diagnosis of intraabdominal graft infections due to the deep location of such grafts and 
the difficulty in discrimination of subtle findings. 
Computed tomography (CT) scan is the most commonly performed study and the standard 
against which all other imaging modalities are compared (Mark et al., 1982). Both 
intravenous and oral contrast media are necessary to identify the graft lumen and the 
relationship of the prosthesis to adjacent structures (FitzGerald et al., 2005). CT scan has 
sensitivity more than 95% and specificity in the range of 85% when the criteria of perigraft 
fluid, perigraft soft tissue attenuation, ectopic gas, pseudoaneurysm, or focal bowel wall 
thickening are used (Balink & Reijnen, 2007). Importantly, CT scan provides an assessment 
of the entire graft in contrast to duplex ultrasound as mentioned before. In the early 
postoperative period, it may be difficult to distinguish graft infection from normal 
postoperative changes even with CT scan. Perigraft air is not common beyond 1 week after 
operation, but it is not pathognomonic of graft infection until 4-7 weeks after surgery 
(Qvarfordt et al., 1985; Soetevent et al., 2004). Similarly, perigraft fluid that persists beyond 4 
months postoperatively is highly suspicious for the presence of infection (Qvarfordt et al., 
1985). In the initial 4 months after surgery, perigraft fluid may be present without infection, 
and CT-guided aspiration may assist with definitive diagnosis when clinical circumstances 
raise such a possibility. 
Magnetic resonance imaging (MRI) has a somewhat higher accuracy for diagnosis of 
intraabdominal graft infections than CT scan because of its superiority for discrimination of 
tissue planes, particularly in the retroperitoneum (Olofsson et al., 1988). Hence, it is quite 
sensitive in the detection of small amounts of perigraft fluid, but differentiation between gas 
in the perigraft space and calcifications in the native arterial wall may be difficult 
(FitzGerald et al., 2005). Owing to signal characteristics on T-1 and T-2 weighted images, 
MRI permits differentiation of perigraft fluid and inflammatory changes of surrounding 
structures from acute and chronic hematoma. However, MRI does not allow distinction 
between the various types of nonhemorrhagic fluid (infected vs. sterile) (Olofsson et al., 
1988). Compared with CT, reconstruction of multiple tissue planes is more easily performed, 
and nephrotoxicity from intravenous agents may be avoided. In conclusion, because of its 
wide availability, lower cost, and high sensitivity and specificity, CT scan should be 
considered the standard reference among imaging modalities for the diagnosis of aortic 
graft infection. Even when graft infection manifests in the groin and documented with the 
use of duplex ultrasound, it is imperative to complement the work-up of the patient with CT 
in order to stage accurately the extent of infection and plan the surgical or conservative 
management. 
Radioisotope scans with labeled leukocytes or immunoglobulin (indium or gallium) may 
confirm the presence of infection and outline its extent. Indium is considered more accurate 
than gallium due to higher background levels caused by nonspecific intestinal uptake of 
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gallium (Mark et al, 1985). Accuracy rates for indium-labeled leukocyte scans are reported to 
be 90% to 100% in most studies, but both false-positive and false-negative results may occur. 
False-positive studies are more common in the first 3-4 months postoperatively, when there 
is normal inflammation in perigraft region. Correlation of positive findings with anatomic 
results from CT or MRI scans is useful to minimize false-positive scans. Several 
modifications of radioisotopic labeling techniques have been used and claimed to supplant 
CT scan as the first line in the diagnosis of aortic graft infections, but none have achieved 
this goal despite their promising initial results (Delgado et al., 1999; Mark et al., 1985; 
Palestro et al., 2001). 
Compared with other anatomic imaging studies, arteriography is of limited value for the 
diagnosis of vascular graft infections because of false-negative results when native vessels 
are not involved in the infectious process. Arteriography is of assistance when planning 
reoperation for aortic graft infection because of its assessment of proximal and distal 
circulations and characterization of graft anastomosis. However, CT angiography or MR 
angiography have been predominated over arteriography, even in operation planning. 
Sinography may demonstrate communication with the prosthetic graft and, thus, definitely 
confirms the diagnosis. However, a negative study does not preclude the presence of 
infection. 
Gastrointestinal endoscopy should be considered in any patient with a possible gastrointestinal 
bleeding source after aortic bypass grafting. Endoscopists should be aware that aortoenteric 
fistula most often occurs in the distal portions of duodenum. The absence of bleeding from 
other gastrointestinal (GI) sources should prompt a high level of suspicion for the presence of 
an aortoenteric fistula, even if there is not clear visualization of the graft or ulceration in the 
duodenum. When other GI sources of bleeding are excluded, surgical exploration and 
inspection of the duodenum and aortic graft may be the only method to confirm or exclude 
aortoenteric fistula before the hemodynamic decompensation of the patient takes place. 
Apart from imaging modalities, blood cultures have an integral part in the evaluation of 
such patients, as they guide the antibiotic coverage, either in the form of preoperative 
preparation of the patient, or in the context of conservative management with preservation 
of the infected graft. 
1.7 Treatment 
1.7.1 Goals 
In dealing with an infected vascular aortic graft, the primary goal of treatment is to save life 
and limb. This can be achieved by initial and long-term eradication of the local and systemic 
septic process and maintenance of normal arterial perfusion to involved tissues. Secondary 
goals are to minimize morbidity, to restore normal function, and to maintain long-term 
function without the need for repeated intervention or amputation.  
1.7.2 Principles of management 
Bunt (Bunt, 2001) has elegantly described 4 principles of management for vascular graft 
infections. First, excision of the graft as a foreign body potentiating infection. Second, wide 
and complete debridement of devitalized and infected tissue to provide a clean wound in 
which healing can occur. Third, establishment of vascular flow to the distal bed. Fourth, 
institution of intensive and prolonged antibiotic coverage to reduce sepsis and prevent 
secondary graft infection. 
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The gold standard for treatment of an infected prosthetic aortic graft remains explantation 
of the graft and reperfusion of the area by placement of a new graft through an extra-
anatomic uninfected route. However, recently it has been recognized that the bacterial 
characteristics of early versus late abdominal graft infections differ (early graft infections 
generally associated with more virulent organisms whereas late graft infections with less 
virulent organisms). Similarly to pathogen factors (type of microorganisms, virulence), the 
extent of graft infection, and antibiotic susceptibility guide appropriate operative selection. 
This has led to a plethora of alternative operative and antimicrobial strategies. Route of 
reconstruction (in situ versus extra-anatomic), timing and sequence of the procedures, type 
of bypass conduit, and manner of excision (partial versus complete) remain under 
controversy. Recently, endovascular options have been proposed, enriching the 
armamentarium of available treatment options, but also complicating the proper decision 
algorithm. The lack of sufficient Level I evidence data, allow occasionally an ad hoc choice 
of the proper treatment in each case (Perera et al., 2006).  
With few exceptions, the treatment of aortic graft infection is surgical. Definitely, patient 
hemodynamic stability and antibiotic coverage are essential. Patients with hemodynamic 
instability secondary to hemorrhage from aortoenteric fistula or ruptured pseudoaneurysms 
require immediate resuscitation and operation. Limited efforts using the dogma of 
hypotensive haemostasis in order to stabilize the patient and allow further evaluation and 
planning may be appropriate. The patient’s condition and ability to tolerate a definitive 
procedure as an emergency must be weighed against the option of a limited initial 
procedure and subsequent definitive management (staged operation).  
1.7.2.1 Antibiotics 
When prosthetic graft infection is suspected, empiric agents should be selected based on the 
presumed organism and expected sensitivities and initiated after appropriate cultures have 
been taken. For example, an early infection should be treated with agents active against 
methicillin-resistant staphylococci and gram-negative bacilli. Late infections that are 
presumed to be caused by coagulase negative staphylococci are treated with vancomycin, 
with or without rifampin (Perera et al., 2006). Antibiotics should be adjusted once the 
etiologic microorganism and its sensitivity have been identified. The length of antibiotic 
coverage is controversial, and recommendations are for a minimum of 2 to 4 weeks of 
parenteral antibiotics (Perera et al., 2006). Oral antibiotics are typically administered for an 
additional 1 to 6 months period, but some authors have recommended lifetime 
administration in cases when preservation of the potentially infected graft is warranted 
(Barrie & Eachempati, 2005). 
There is no consensus on which agents are preferred for initial empiric therapy before 
adjustments can be made based on culture results. The British Society of Antimicrobial 
Chemotherapy (BSAC) Steering Group on the treatment of hospital infections has 
recommended treatment with cefuroxime and metronidazole, with or without amoxicillin, 
as suitable empirical therapy for early-onset prosthetic vascular graft infections. 
Ciprofloxacin and clindamycin should be considered as second line treatment in penicillin-
allergic patients. However, as S. aureus is the organism most likely to be isolated in early-
onset infections and, as methicillin resistance is increasingly common, empirical treatment 
should include a glycopeptides according to regional epidemiologic data (Darouiche, 1994). 
With regard to late-onset infections, guidelines recommend that antibiotic treatment be 
deferred until the infective etiology has been confirmed, except in the critically ill (. 
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1.7.2.2 Surgery 
Succesful surgical treatment of aortic graft infection requires balancing strict adherence to 
the principles of managing the problem while trying to predict a patients’ ability to 
withstand the proposed operation. Operative strategies include graft excision without 
revascularization, graft excision with extra-anatomic bypass procedures, and graft excision 
with in situ reconstruction using a prosthetic conduit, allograft, or autogenous tissue. 
The extent of graft involvement should guide the extent and type of the operation, and, 
thus, should be scrutinized thoroughly. Limited infections may be treated by excision of the 
involved segment and preservation of the uninvolved, well-incorporated graft. Because 
graft infection may be more extensive at operation than indicated by preoperative studies, 
the surgeon should be prepared to change his/her plan according to the intraoperative 
findings. 
As there is no evidence-based support for the efficacy, safety, and appropriateness of the 
graft salvage approach in the routine management of patients with aortic graft infections, 
and details of its outcomes come from case reports and series only, the explantation of the 
graft and vascular reconstruction is still considered the sine qua non for these patients to be 
cured. All of the reconstructive options are valid and appropriate depending upon patient 
characteristics, extent and virulence of infection, and severity of underlying vascular 
disease. It is a mistake to think that a single surgical approach is applicable to all patients 
with this condition. Knowing the pros and cons of each procedure, the vascular surgeon can 
tailor the surgical plan to the individualized requirements, and achieve the best outcome 
possible in each case.  
1.7.3 Restoring perfusion in lower limbs 
a. No revascularization 
Graft excision without revascularization is associated with a 33-36% amputation rate and is 
rarely performed today (Bunt, 2001). It is usually reserved for patients with aortic graft 
infections with known thrombosed grafts but yet viable extremities. Often, the original 
indication for graft placement, as well as whether the graft was placed in an end-to-end or 
end-to-side manner is a crucial factor in determining the need for distal revascularization. 
The degree of limb ischemia and presence of collateral circulation are the most important 
aspects of selecting this option. For example, patients having grafts placed for occlusive 
disease with rest pain or tissue loss are more likely to need a bypass to restore blood to the 
distal bed. On the contrary, patients that had an aortic graft implantation for purely 
aneurysmal disease or claudication may not necessarily require a lower limbs 
revascularization procedure. Also, grafts having end-to-side configuration are more likely to 
have native collateral circulation still intact, thus being less likely to require a lower 
extremity revascularization.  
b. Extra-anatomic bypass 
Extra-anatomic bypass is a good option for the treatment of an infected aortic graft when 
groin infection is absent and lower extremity run-off is good. For instance, extra-anatomic 
bypass would be an excellent choice in a patient with an infected aortoiliac graft. The 
mortality and morbidity of this approach has decreased significantly since evidence 
supported preceding graft excision with extra-anatomic bypass rather than exploration and 
resection of the graft as the initial step. This reduces the duration of peripheral ischemia, 
operative blood loss, and attendant complications. One can stage the procedure by one or 
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several days, especially in critically ill patients that require stabilization (Seeger et al., 2000). 
In the stable and good risk patient, we favor proceeding with graft excision under the same 
anesthetic, although there is only little evidence that the new extra-anatomic graft will 
experience thrombosis or become secondarily infected during the interval (Landry et al., 
2000). Conversely, in patients who are bleeding the initial step should be exploration and 
removal of the infected graft. 
In cases that involve groin infection due to prior aortofemoral bypass graft, the extra-
anatomic reconstruction involves constructing the new femoral anastomosis to the profunda 
femoral artery (or superficial femoral artery) beyond the inguinal region through a lateral 
incision distal to the original femoral anastomosis. In these cases the PTFE axillofemoral 
graft is routed lateral to the anterior superior iliac spine circumventing the infected, original 
femoral incision. It should be emphasized that the aortic suture line, during aortic graft 
explantation, must be excised back to viable aortic tissue and oversewn in two layers with 
propylene suture, using omentum or prevertebral fascia to support the suture line. If 
necessary, one or both renal arteries may be sacrificed to obtain a satisfactory aortic stump 
closure, and splenorenal or hepatorenal bypass (or both) is carried out as needed. The 
periaortic tissue should be cultured and aggressively debrided. 
The advantages of extra-anatomic bypass are that they may be physiologically less stressful 
to the patient, especially in the context of staged approach, they are technically 
straightforward, and there is minimal lower extremity ischemic time (Lehnert et al., 1993). 
The disadvantages consist in poor patency (about 60% at 5 years), especially in patients with 
multilevel occlusive disease, a 10% to 20% reinfection rate, that often proves fatal, the 
potential of aortic stump blow out, the high long-term amputation rate, estimated in the 
range of 30%, and the need for lifelong antithrombotic therapy (Lehnert et al., 1993; Mussa 
et al., 2007).Reinfection of extra-anatomic bypass following removal of an infected aortic 
prosthesis is a limb- and life-threatening problem about which little is known (Gordon et al., 
1999). Thre are few options left other than to try to construct a new extra-anatomic bypass 
through uninfected tissues. This is usually not feasible, especially when distal, femoral 
anastomotic sites are involved with infection. Gorgon et al, has performed in situ femoral-
popliteal vein reconstruction along with removal of the infected extra-anatomic bypass with 
satisfactory results (Gordon et al., 1999). 
c. In-situ reconstruction 
Because of persistent problems with durability and patency, as well as the other 
aforementioned complications, many authors have advocated the use of in situ 
reconstructions (Bandyk et al., 2001; Clagett et al., 1997; Noel et al., 2002). In situ arterial 
allografts were used extensively for infrarenal aortic replacement during the first decade of 
aortic surgery, but they were abandoned in the early 1960’s due to difficulties in 
procurement and preservation, late degeneration, and availability of suitable aortic 
prosthetic grafts (DeBakey & Creech, 1954; Oudot & Beaconsfield, 1953). Allograft 
replacement, compared with the conventional method of graft excision and axillofemoral 
bypass, has the advantages of being expedient, associated with lower amputation rates (on 
the average 2%), and averting complications such as aortic stump blow out and reinfection 
or occlusion events (Verhelst et al., 2000). It also enables surgical reconstruction of 
hypogastric and deep femoral arteries, as indicated, thereby preventing the development of 
postoperative ischemic colitis or lower limb ischemia. However, mixed results have been 
reported regarding the efficacy of in situ replacement of infected aortic grafts with arterial 
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homografts (Vogt et al., 1996). In one report, a 20% mortality was associated with this 
method of treatment (Speziale et al., 1997). Aortic allografts are also subject to long-term 
complications such as aneurysmal dilation, late allograft rupture, and thrombosis (Brown et 
al., 2009). Reinfection of allografts, although lower than in extra-anatomic bypass grafting, 
may also occur and usually proves fatal. Currently, aortic allografts are available only on a 
limited basis. Their shortage diminishes their use in situations where they may be most 
useful, namely in patients who are unstable, for example, those with actively bleeding 
aortoenteric fistula. 
The same advantages and disadvantages accompany the use of antibiotic-treated prosthetic 
grafts. Their placement is expedient and technically straightforward, thus rendering them a 
reasonable option in critically ill, unstable patients. Moreover, they leave no aortic stump 
and are associated with relatively low amputation rate (Batt et al., 2003). We do not use in 
situ replacement with antibiotic-coated prosthetic grafts as the reported results are very 
poor, except in the replacement of one limb of an aortic graft infected with Staphylococcus 
epidermitis (Young et al., 1999). We have occasionally used such grafts in the initial 
temporizing treatment of aortoenteric fistula, thereby converting an unstable patient into a 
more stable with an infected aortic graft needing further treatment. Typically, the new 
prosthetic graft is soaked in rifampin, 60mg/ml, for 15 minutes before implantation (Walker 
et al., 1987). However, the reinfection rate is high and unpredictable, and patients must 
undergo lifelong antibiotic therapy. 
d. Neo-aortoiliac bypass procedures 
Because of the limitations of the other procedures, the use of in situ autogenous venous 
reconstruction technique, also termed neoaortoiliac system or NAIS procedure, has 
known great advocacy since its first description by Clagett in 1993 (Clagett et al., 1993). 
We should give credit to Erenfield who introduced first the concept of autogenous 
replacement of infected aortic grafts but it was Clagett’ s introduction of the graft 
constructed of femoral popliteal veins that made the routine use of this method feasible. 
Early attempts that made use of greater saphenous vein grafts proved unsuccessful 
because the small caliber of the venous conduit resulted in low patency rates. Subsequent 
attempts using larger-caliber femoropopliteal (FPV) vein grafts, proved highly successful. 
FPV grafts have excellent long-term patency and are resistant to reinfection. Moreover, 
they are ideal conduits for patients with multilevel occlusive disease, in whom venous 
grafts would have better patency than prosthetic grafts. The 5-year patency rates for 
aortoiliac/aortofemoral reconstructions using FPV grafts range from 85% to 100% (Beck et 
al., 2008). According to the conventional method described by D’Addio and Clagett in 
1993, the patient is prepared and draped from the nipples to the feet under general 
anesthesia (Clagett et al., 1993). A longitudinal incision along the course of the Sartorius 
muscle is used to expose an adequate length of the deep femoral and popliteal veins. The 
side branches are divided and ligated. Care is taken to preserve the profunda femoris vein 
in order to reduce the incidence of postoperative venous hypertension. The aortic graft is 
then exposed, either through a transperitoneal or retroperitoneal exposure and excised. 
Complete debridement of the aorta and surrounding tissues is performed. A sufficient 
length of deep vein is harvested. Reconstruction of the aortofemoral continuity is 
accomplished by either creating a bifurcated pantaloon graft, or by a unilateral 
aortofemoral graft, combined with an iliofemoral crossover graft. 
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A modification of the conventional NAIS procedure has been advocated by many authors in 
recent years. It is termed staged NAIS and refers to any aortoiliofemoral reconstruction 
using deep femoral popliteal veins in the treatment of aortic graft infections that is not 
completed in a single operation (Ali et al., 2008). At the initial operation, the deep veins are 
exposed, the side branches are divided and suture-ligated, and the incisions temporarily 
closed over closed-suction drains. The femoral veins are left in situ, so that flow is not 
interrupted. Overnight, sequential, compression devices are recommended, in addition to 
the use of low molecular weight heparin, as a prophylaxis against deep vein thrombosis. 
The next day, the infected aortic graft is excised and the aortic reconstruction performed. In 
selected patients with graft occlusion and ischemia, the NAIS procedure may be further 
staged by performing unilateral revascularization of the most ischemic leg first, followed by 
revascularization of the contralateral limb at a later date.  
Harvest of the deep vein is a critical part of the operation and has to be done meticulously. 
The staging of NAIS procedure, with harvesting the vein a day before definitive 
reconstruction, does not seem to cause any ill effects, and, in fact, may be beneficial in 
selected groups of patients (Modral et al., 2004). Especially in the presence of limb-
threatening ischemia in conjunction with aortic graft infection, the advocates of the staged 
version, argue that deep femoral popiliteal vein mobilization may cause disruption of 
collaterals and precipitate acute ischemia. In such cases, the authors recommend that 
aortofemoral bypass be performed in the ischemic limb first, followed by femorofemoral 
bypass to the contralateral limb within 4 to 18 days later (Ali et al., 2008). 
The advantages of autogenous femoroepopliteal vein replacement (NAIS) can be 
summarized as follows: a) superior long-term patency, limb salvage, b) minimal chance or 
reinfection, c) no aortic stump in the context of infected field, d) long-term 
antibiotic/antithrombotic therapy unnecessary (Lopera et al., 2008). Although reasonable 
limb salvage rates can be achieved using extra-anatomic bypass, achieving this goal requires 
careful follow up and multiple graft revisions or even new graft procedures. The advent of 
NAIS procedure has essentially obliterated the need for a secondary intervention in such 
fragile patients. 
The main disadvantage is that the procedure is time consuming and technically demanding. 
The mean operating time is 8 hors and the lower extremity ischemic time is longer than that 
of patients undergoing the other procedures (Lopera et al., 2008). An additional 
disadvantage is the 20% incidence of short-term venous morbidity requiring leg fasciotomy 
(Modral et al., 2004). 
A modification of the NAIS procedure with the use of the superficial femoral arteries as 
autologous neo-aortoiliac grafts have sporadically been reported in the literature as well 
(Dinis de Gama et al., 2004).  
e. Conservative treatment 
In an attempt to avoid submitting high-risk patients to a complex procedure with high 
morbidity and mortality, many authors have reported on a more conservative strategy, 
including aggressive local wound care with preservation of most, or all, of the involved 
graft (Calligaro et al., 2003). Although traditionally used in peripheral vascular graft 
infections, local care may also be carried out in selected patients with aortic graft infection. 
So, when clinical signs and preoperative imaging studies indicate that the infection is 
localized to the groin in a patient having undergone an aortofemoral bypass, drainage of all 
gross infection, extensive soft-tissue debridement, repetitive wound dressing changes, and 
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the administration of antibiotics both topically and parenterally may effect sterilization of 
the wound and allow healing to occur by secondary intention. There have been few if any 
well-designed trials to study antimicrobial therapy as the main treatment of prosthetic aortic 
graft infection. Most studies are carried out by surgeons, and, as such, antibiotic therapy is 
mentioned as adjunct to surgical treatment. There is no evidence on which to decide the 
optimal duration of antibiotic administration (Perera et al., 2006).  As mentioned above, this 
may vary from 2 weeks to one year, although a minimum of 4-6 weeks of intravenous 
therapy, followed by up to 6 months of oral therapy is commonly recommended 
(Nevelsteen et al., 1995). A small number of cases in which operation was deemed an 
unacceptably high risk to the patient have reported success with long-term suppressive 
treatment, including in some occasions lifelong antibiotic administration (Baddour, 2001; 
Roy & Grove, 2000). 
A recent addition to our therapeutic armamentarium in managing infected aortic graft 
infection, when infection is suspected to be confined to one or both groins and the patient 
considered high risk to be submitted to operation, has been the use of a vacuum-assisted 
closure system (VAC). It has been reported that VAC therapy reduces the bacteria count in 
open wounds; removing excess fluid in the wound may stimulate lymphatic and blood flow 
and increase oxygen concentration, thereby killing bacteria (Dosluoglu et al., 2005). Further 
experience is necessary to evaluate the potential for VAC therapy to eradicate graft 
infections in the groin.    
Although a trial of graft salvage is considered warranted in selected patients, as it avoids the 
morbidity inherent in excising the original graft and performing arterial ligation and repair 
in an infected field and obviates the necessity to perform an extra-anatomic bypass that is 
susceptible to recurrent thrombotic episodes, there are several disadvantages to this 
approach. A protracted period of hospitalization is required at considerable financial cost, 
and during this interval, the graft and patient are vulnerable to a number of complications 
such as anastomotic hemorrhage, thrombosis, and superinfection with more virulent 
organisms. A baseline CT scan is performed in these patients prior to discharge. This 
examination serves as a useful scan for comparison during routine follow-up or if patients 
develop additional septic or graft complications. 
In the absence of evidence or consensus the treatment of aortic graft infection is often 
somewhat ad hoc and varies from center to center. As a conclusion of what previously 
described, two are the main criteria of choosing a plan of action. First the extent of graft 
infection, according to the Szilagyi and Samson criteria, and second, the microorganism 
cultured. Patients with limited graft infection (Samson 3, i.e. involving the body of the graft 
but not at an anastomosis) can be considered for graft salvage or route salvage (in situ 
reconstruction), with aggressive debridement with muscle transposition. On the contrary, 
graft salvage likely has limited application in advanced infection (Sampson 4 & 5, i.e. 
infection surrounding an exposed anastomosis with or without bacteremia). In these cases, 
the current literature suggests excision of the graft and it should be performed if tolerated. 
With regard to the microorganisms cultured, graft preservation or in situ reconstructions 
should be attempted when low virulence organisms are found, such as S. epidermidis. 
Methicillin resistant S. aureus and gram negative bacteria when met in graft infection 
should lead to graft explantation and extra-anatomical arterial reconstruction, unless when 
there is only minor graft involvement.  
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1.8 Endovascular stent graft infection 
There has been no reason to believe that endovascular aortic stent grafts would be immune 
from septic complications, particularly because these procedures are increasingly being 
performed outside of the formal operating room and by nonsurgical vascular specialists. 
The infection rate of endovascular grafts implanted for abdominal aortic aneurysm disease 
is unclear, but Fiorani et al estimated a rate around 0,4% (Fiorani et al., 2003). Due to the 
minimal invasive nature of the procedure compared with the open counterpart, it is 
expected to be associated with lower septic complications. 
The pathogenetic mechanisms of endograft infections consist mainly due to the following 
reasons: 
1. Breaks in sterile technique during its implantation,  
2. Superinfection during bacteremia from a variety of sources,  
3. Severe intraperitoneal or retroperitoneal inflammation (i.e. rupture of hollow viscus, 
necrotizing pancreatitis), 
4. Inoculation of bacteria during postoperative percutaneous interventions to manage 
various types of endoleaks (Hulin & Morris, 2007).  
5. External injury of endograft (Lazaris et al., 2009).  
The management of patients with infected aortic endografts must be based on the same 
fundamental principles as those analyzed above. The gold standard involves the 
explantation of the graft with subsequent reconstruction according to individualized 
parameters (Setacci et al., 2010). Some reports on the use of surgical or percutaneous 
placement of drains into the aneurysmal sac abscess contiguous to the graft in conjuction 
with irrigation of the perigraft area with antibiotic instilled through the drains and 
simultaneous systemic antibiotics administration, show promising results and have altered 
the approach to patients without signs of severe sepsis (Blanch et al., 2010; Pryluck et al., 
2010). 
1.9 Outcome 
The perioperative mortality in patients with aortic prosthetic graft infection has improved 
over the past two decades. The conventional approach of graft removal and extra-anatomic 
reconstruction is associated with 12% mortality and 2% incidence of aortic stump 
infection/disruption (2). Three-year survival is estimated at 63% (Kitamura et al., 2005). 
Clearly, axillofemoral graft complications occur more frequently in patients with infected 
aortofemoral prosthetic grafts than in those with aortoiliac bypasses. This is specifically 
related to the technical challenge posed when attempting to avoid infection in the femoral 
region and simultaneously construct a durable prosthetic extra-anatomic bypass. On the 
other hand, the autogenous femoral vein graft is resistant to infection and appears to have a 
2-year patency rate that exceeds 90% (Ali et al., 2008). 
2. Conclusion 
Aortic graft infections could be considered as the most dreadful complications that a 
vascular surgeon may encounter with. However, there are therapeutic options that can 
achieve remarkable results. Achieving the best result requires that the attending vascular 
surgeon takes advantage of the best features of each of the management plans available in 
his/her armamentarium. None of the approaches described here represents a perfect 
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solution to the problem. What has become clear in recent years, however, is that although 
many patients with graft sepsis will continue to require graft explantation, an increasing 
number of autogenous and allograft options are available that offer the opportunity to 
maintain in-line anatomic arterial perfusion and preserve long-term limb viability.   
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